Candriam S.C.A.
Institutional investor · Portfolio as of Q2 2020
Top Holdings802 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
MICROSOFT CORP | 2.1M | $434.8M | 4.6% | $118.10 | +60.42% | 6 qtrssince 2019-Q1 | Decreased 0 |
APPLE INC | 631,936 | $230.5M | 2.4% | $46.11 | +91.32% | 6 qtrssince 2019-Q1 | Decreased 0 |
ALPHABET INC-CL A | 158,986 | $225.5M | 2.4% | $59.40 | +16.72% | 6 qtrssince 2019-Q1 | Decreased 0 |
AMAZON.COM INC | 80,801 | $222.9M | 2.4% | $89.53 | +49.70% | 6 qtrssince 2019-Q1 | Increased 53 |
AMGEN INC | 871,290 | $205.5M | 2.2% | $152.23 | +28.73% | 6 qtrssince 2019-Q1 | Decreased 0 |
VERTEX PHARMACEUTICALS INC | 546,191 | $158.6M | 1.7% | $183.78 | +55.17% | 6 qtrssince 2019-Q1 | Decreased 0 |
MERCK & CO. INC. | 2M | $157.6M | 1.7% | $63.33 | -3.61% | 6 qtrssince 2019-Q1 | Increased 65 |
REGENERON PHARMACEUTICALS | 228,901 | $142.8M | 1.5% | $390.55 | +55.55% | 6 qtrssince 2019-Q1 | Decreased 0 |
META PLATFORMS INC-CLASS A | 605,114 | $137.4M | 1.5% | $174.46 | +25.59% | 6 qtrssince 2019-Q1 | Increased 52 |
GILEAD SCIENCES INC | 1.7M | $130M | 1.4% | $50.05 | +20.32% | 6 qtrssince 2019-Q1 | Decreased 0 |
PAYPAL HOLDINGS INC | 619,403 | $107.9M | 1.1% | $115.00 | +46.05% | 6 qtrssince 2019-Q1 | Increased 57 |
DANAHER CORP | 594,284 | $105.1M | 1.1% | $136.18 | +9.60% | 6 qtrssince 2019-Q1 | Increased 74 |
PROCTER & GAMBLE CO/THE | 859,359 | $102.8M | 1.1% | $88.22 | +15.61% | 6 qtrssince 2019-Q1 | Decreased 0 |
THERMO FISHER SCIENTIFIC INC | 266,341 | $96.5M | 1.0% | $313.09 | +10.47% | 6 qtrssince 2019-Q1 | Increased 71 |
BIOGEN IDEC INC | 340,919 | $91.2M | 1.0% | $236.38 | +10.14% | 6 qtrssince 2019-Q1 | Decreased 0 |
BRISTOL-MYERS SQUIBB CO | 1.5M | $88.5M | 0.9% | $36.62 | +26.49% | 6 qtrssince 2019-Q1 | Decreased 0 |
VISA INC-CLASS A SHARES | 379,065 | $73.2M | 0.8% | $148.12 | +24.64% | 6 qtrssince 2019-Q1 | Decreased 0 |
ALIBABA GROUP HOLDING-SP ADR | 329,846 | $71.2M | 0.8% | $171.52 | +18.34% | 6 qtrssince 2019-Q1 | Decreased 0 |
AUTODESK INC | 297,114 | $71.1M | 0.8% | $161.33 | +43.91% | 6 qtrssince 2019-Q1 | Increased 43 |
BLUEPRINT MEDICINES CORP | 878,644 | $68.5M | 0.7% | — | — | 3 qtrssince 2019-Q4 | Increased 67 |
Candriam S.C.A. manages $9.5B across 802 positions as of Q2 2020. Top holdings: MSFT (4.6%), AAPL (2.4%), GOOGL (2.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Active quarter - 114 new positions, 110 exits, 261 increased. Top move: DHR (INCREASED, conviction 74). Portfolio: $9.5B across 802 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer